Metagenomi, Inc.
MGX
$1.86
-$0.05-2.62%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -39.62% | -4.22% | 16.84% | 45.13% | 83.36% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -39.62% | -4.22% | 16.84% | 45.13% | 83.36% |
| Cost of Revenue | -12.83% | -2.68% | 15.65% | 30.77% | 61.16% |
| Gross Profit | -14.22% | 1.43% | -14.58% | -19.12% | -43.61% |
| SG&A Expenses | -13.77% | -3.41% | 11.00% | 20.05% | 38.05% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -13.04% | -2.84% | 14.56% | 28.16% | 55.21% |
| Operating Income | -3.76% | 2.12% | -13.26% | -19.46% | -41.48% |
| Income Before Tax | -23.23% | -16.69% | -38.76% | -31.50% | -50.83% |
| Income Tax Expenses | -283.04% | -192.88% | -168.68% | -125.69% | -68.90% |
| Earnings from Continuing Operations | -16.16% | -0.88% | -14.36% | -16.30% | -38.51% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.16% | -0.88% | -14.36% | -16.30% | -38.51% |
| EBIT | -3.76% | 2.12% | -13.26% | -19.46% | -41.48% |
| EBITDA | -3.29% | 3.24% | -12.40% | -18.47% | -40.46% |
| EPS Basic | 81.88% | 85.17% | 85.24% | 53.26% | 4.78% |
| Normalized Basic EPS | 81.86% | 84.76% | 84.30% | 54.63% | 6.16% |
| EPS Diluted | 81.88% | 85.17% | 85.24% | 53.26% | 4.78% |
| Normalized Diluted EPS | 81.86% | 84.76% | 84.30% | 54.63% | 6.16% |
| Average Basic Shares Outstanding | 129.58% | 305.40% | 604.84% | 423.59% | 245.35% |
| Average Diluted Shares Outstanding | 129.58% | 305.40% | 604.84% | 423.59% | 245.35% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |